Mucormycosis risk mitigation in the COVID battle Updated: Updated: May 13, 2021 23:46 IST Diabetes control can lower the chances of dangerous side-effects in COVID-19 treatment such as this fungal infection Share Article AAA Diabetes control can lower the chances of dangerous side-effects in COVID-19 treatment such as this fungal infection The COVID-19 pandemic continues to play havoc all over the world and India is no exception to this. While 70%-80% of those affected with COVID-19 recover without many side-effects, about 20%-30% of patients affected with symptomatic COVID-19 might require hospitalisation — here, a minority can get worse and require treatment in an intensive care unit (ICU). Ever since the COVID-19 pandemic was first described from Wuhan in China, it is quite clear that it is people with comorbidities such as being of an older age, obese, having uncontrolled diabetes, heart or respiratory diseases and malignancies, who fare badly.